London biometrics research firm expands global footprint with US acquisition

Specialist Biometrics CRO Veramed has announced the acquisition of Boston based data management, biostatistics and medical writing company, CTDS. The deal will enhance Veramed’s global presence and broaden the company’s data management capability.

Matt Jones, Co-Founder and CEO of Veramed, commented: “The combination of CTDS and Veramed will grow our team to over 350 trusted statisticians, programmers and data managers globally and enhance our ability to provide end-to-end biometrics support.

“We believe that the benefits of the combination will be felt by the customers and staff of both organisations and open the door to exciting opportunities with new partners.”

Terri Sampo, Principal Consultant and Founder of CTDS, added: “We are excited to have joined the Veramed family and to bring together our teams of talented biostatistics, data management and medical writing experts to create a comprehensive and dynamic offering in the market.

“Specialised biometrics and data management providers are proving to be an effective solution to the biotech industry’s need for flexibility, speed and agility.

These providers offer specialised expertise in data collection and analysis, ensure accurate results; maintain data quality and regulatory compliance; enhance resource efficiency; expedite decision-making; and provide tailored solutions to sponsor companies.

Collaborating with companies like Veramed mitigates risks, provides access to advanced tools, and boosts credibility with biotech investors, contributing to more effective research, quicker decision-making, and improved prospects for funding and success.

Founded in 2005 by Terri Sampo, Clinical Trial Data Services supports small to midsize sponsor companies helping them to take the next step towards market approval for their drug or device product.

CTDS’s oversight, personalised service and understanding and dedication to process is described as a ‘perfect fit’ for Veramed’s existing reputation for ‘quality and delivery’.

Emma Jones, Co-Founder and Executive Vice President of Statistics at Veramed, concluded: “We were immediately impressed with CTDS’s core values and clear dedication to providing tailored solutions to their clients. We are confident this is a great fit and are looking forward to the future.”

By Matthew Neville – Senior Correspondent, Bdaily

• Add me on LinkedIn and Twitter to keep up to date
• And follow Bdaily on Facebook, Twitter and LinkedIn
• Submit press releases to editor@bdaily.co.uk for consideration.